A detailed history of Sage Capital Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Sage Capital Management, LLC holds 13,785 shares of PFE stock, worth $392,321. This represents 0.2% of its overall portfolio holdings.

Number of Shares
13,785
Holding current value
$392,321
% of portfolio
0.2%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

BUY
$25.26 - $29.6 $348,209 - $408,036
13,785 New
13,785 $386 Million
Q1 2024

Jul 31, 2024

BUY
$25.89 - $29.73 $18,330 - $21,048
708 Added 5.14%
14,493 $402 Million
Q4 2023

Jul 31, 2024

BUY
$26.13 - $33.94 $174,914 - $227,194
6,694 Added 48.56%
20,479 $590 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $160B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Sage Capital Management, LLC Portfolio

Follow Sage Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sage Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sage Capital Management, LLC with notifications on news.